mobiquity_technoliges_logo.jpg
Mobiquity Technologies' ElecTech Platform: Changing the Landscape of Political Campaign Engagement
23 août 2023 08h00 HE | Mobiquity Technologies, Inc.
NEW YORK, Aug. 23, 2023 (GLOBE NEWSWIRE) -- Mobiquity Technologies, Inc. (Nasdaq: MOBQ), a leading provider of next-generation data intelligence and advertising technology solutions, announces its...
mobiquity_technoliges_logo.jpg
Mobiquity Technologies and Optical Near ME Rollout Joint Marketing Program to Eye Care Industry with Next-Generation Marketing Solutions
01 août 2023 08h00 HE | Mobiquity Technologies, Inc.
NEW YORK, Aug. 01, 2023 (GLOBE NEWSWIRE) -- Mobiquity Technologies, Inc. (NASDAQ: MOBQ) (the “Company”), a leading provider of next-generation data intelligence and advertising technology solutions,...
mobiquity_technoliges_logo.jpg
Mobiquity Signs Strategic Alliances to Bring Additional Demand to Its 1st Party Ad Serving Platform for Publishers
26 juil. 2023 08h00 HE | Mobiquity Technologies, Inc.
NEW YORK, July 26, 2023 (GLOBE NEWSWIRE) -- Mobiquity Technologies, Inc. (NASDAQ: MOBQ) (the “Company”), a leading provider of next-generation data intelligence and advertising technology solutions,...
mobiquity_technoliges_logo.jpg
Mobiquity Technologies Announces Strategic Partnership with Optical Near ME to Integrate Advertising into AI-Driven, Immersive Optometry Marketing and Communications
18 juil. 2023 08h00 HE | Mobiquity Technologies, Inc.
NEW YORK, July 18, 2023 (GLOBE NEWSWIRE) -- Mobiquity Technologies, Inc. (NASDAQ: MOBQ) (the “Company”), a leading provider of next-generation data intelligence and advertising technology solutions,...
Cingulate_Logo_400x400_twitter.jpg
Cingulate Announces Positive Top-Line Results from Phase 3 Adult Efficacy and Safety Trial of CTx-1301 (dexmethylphenidate) for ADHD
11 juil. 2023 08h00 HE | Cingulate Inc.
KANSAS CITY, Kan., July 11, 2023 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform...
mobiquity_technoliges_logo.jpg
Mobiquity Technologies and ElecTech: AI-Driven Successes in Primary Elections
10 juil. 2023 08h30 HE | Mobiquity Technologies, Inc.
NEW YORK, July 10, 2023 (GLOBE NEWSWIRE) -- Mobiquity Technologies, Inc. (NASDAQ: MOBQ) (the “Company”), a leading provider of next-generation data intelligence and advertising technology solutions,...
mobiquity_technoliges_logo.jpg
Mobiquity Technologies Enhances ElecTech and ElecAlytics A.I. Platforms to Create More Personalized Audience Connections
05 juil. 2023 08h00 HE | Mobiquity Technologies, Inc.
NEW YORK, July 05, 2023 (GLOBE NEWSWIRE) -- Mobiquity Technologies, Inc. (NASDAQ: MOBQ) (the “Company”), a leading provider of next-generation data intelligence and advertising technology solutions,...
Cingulate_Logo_400x400_twitter.jpg
Cingulate Successfully Manufactures Clinical Supply – Initiation of Pediatric Phase 3 Studies to Commence in July and August
29 juin 2023 08h00 HE | Cingulate Inc.
KANSAS CITY, Kan., June 29, 2023 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform...
Cingulate_Logo_400x400_twitter.jpg
Cingulate Completes Phase 3 Adult Trial of CTx-1301 (dexmethylphenidate) for ADHD
08 juin 2023 07h00 HE | Cingulate Inc.
Study Assessed Onset and Duration of CTx-1301 in Adults, Results Expected 3Q 2023 Pivotal Phase 3 Trials in Pediatric/Adolescent Patients on Schedule for 3Q 2023 Initiation KANSAS CITY, Kan., June ...
mobiquity_technoliges_logo.jpg
Mobiquity Technologies Launches ElecAlytics, an AI-Powered Analytics Suite Added to Its ElecTech Platform for Political Campaigns
07 juin 2023 08h00 HE | Mobiquity Technologies, Inc.
NEW YORK, June 07, 2023 (GLOBE NEWSWIRE) -- Mobiquity Technologies, Inc. (NASDAQ: MOBQ) (the “Company”), a leading provider of next-generation data intelligence and advertising technology solutions,...